These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28411790)

  • 1. The use of gentian violet 2% solution to identify holes in the deep margin of tissue excised during Mohs micrographic surgery.
    Shin TM; Etzkorn JR; Sobanko JF; Shaikh WR; Kovach SJ; Miller CJ
    J Am Acad Dermatol; 2017 May; 76(5):e169-e171. PubMed ID: 28411790
    [No Abstract]   [Full Text] [Related]  

  • 2. Surgical margins in the treatment of nonmelanoma skin cancer and mohs micrographic surgery.
    Lane JE; Kent DE
    Curr Surg; 2005; 62(5):518-26. PubMed ID: 16125611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep initial Mohs stage for scalp cutaneous squamous cell carcinoma to avoid occult tumor.
    Lederhandler M; Stokar E; Meehan SA; Geronemus RG
    J Am Acad Dermatol; 2020 Apr; 82(4):e129-e130. PubMed ID: 31836558
    [No Abstract]   [Full Text] [Related]  

  • 4. Maintaining tissue orientation during mohs micrographic surgery: scalpel versus marker.
    Bagheri S; King T; Justiniano H; Eisen DB
    Dermatol Surg; 2011 Oct; 37(10):1412-6. PubMed ID: 22092941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The perineural corona sign: enhancing detection of perineural squamous cell carcinoma during Mohs micrographic surgery with toluidine blue stain.
    Drosou A; Trieu D; Goldberg LH; Kimyai-Asadi A
    J Am Acad Dermatol; 2014 Oct; 71(4):826-7. PubMed ID: 25219703
    [No Abstract]   [Full Text] [Related]  

  • 6. Using frozen section margin control technique to manage non-melanomatous skin lesions in high-risk sites.
    Nizamoglu M; Douglas H; McArdle C; Mathew B; Vize C; Matteucci P
    J Plast Reconstr Aesthet Surg; 2016 May; 69(5):657-62. PubMed ID: 26850755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suggested excisional margins for cutaneous malignant lesions based on Mohs micrographic surgery.
    Schell AE; Russell MA; Park SS
    JAMA Facial Plast Surg; 2013; 15(5):337-43. PubMed ID: 23744451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mohs micrographic surgery: a synopsis.
    Stone JL
    Hawaii Med J; 1993 May; 52(5):134-9. PubMed ID: 8320092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Margin Reanalysis With 3-Dimensional Micrographic Surgery Technique of Conventional Excision Specimens With Negative Margin Readings.
    Magliano J; Navarrete J; Lezue V; González A; Martínez M; Bazzano C
    Am J Dermatopathol; 2021 Jul; 43(7):485-488. PubMed ID: 32956098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral in-continuity tissue examination: a modification of Mohs' micrographic surgery.
    Strong JW; Worsham GF; Hagerty RC
    Clin Plast Surg; 2004 Jan; 31(1):1-4. PubMed ID: 15022789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mohs surgery for squamous cell carcinoma.
    Belkin D; Carucci JA
    Dermatol Clin; 2011 Apr; 29(2):161-74, vii. PubMed ID: 21421142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioimpedance measurement as an assessment of margin positivity in Mohs surgical specimens of nonmelanoma skin cancer: Management implications.
    Svoboda RM; Gharia MJ; Shell J; Gregory WD
    J Am Acad Dermatol; 2018 Sep; 79(3):591-593. PubMed ID: 29544743
    [No Abstract]   [Full Text] [Related]  

  • 13. Current concepts: the use of immunoperoxidase techniques in mohs micrographic surgery.
    Mondragon RM; Barrett TL
    J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):66-71. PubMed ID: 10863226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative and Qualitative Comparison of Two Hematoxylin and Eosin Staining Protocols for Mohs Micrographic Surgery: A Pilot Study.
    Surprenant D; Reserva J; Krol C; Alam M
    Dermatol Surg; 2021 Nov; 47(11):1502-1504. PubMed ID: 34699441
    [No Abstract]   [Full Text] [Related]  

  • 15. Ex vivo fluorescence confocal microscopy in conjunction with Mohs micrographic surgery for cutaneous squamous cell carcinoma.
    Longo C; Ragazzi M; Gardini S; Piana S; Moscarella E; Lallas A; Raucci M; Argenziano G; Pellacani G
    J Am Acad Dermatol; 2015 Aug; 73(2):321-2. PubMed ID: 26183978
    [No Abstract]   [Full Text] [Related]  

  • 16. Low recurrence rates for challenging squamous cell carcinomas using Mohs micrographic surgery with AE1/AE3 cytokeratin immunostaining.
    Aizman L; Miller CJ; Perz AM; Lukowiak TM; Cohen OG; Bean E; Hitchner MK; Etzkorn JR; Shin TM; Higgins HW; Giordano CN; Cohen JV; Miura JT; Sobanko JF
    J Am Acad Dermatol; 2021 May; 84(5):1453-1455. PubMed ID: 32622892
    [No Abstract]   [Full Text] [Related]  

  • 17. Mohs micrographic surgery: technical difficulties posed by perineural invasion.
    Matorin PA; Wagner RF
    Int J Dermatol; 1992 Feb; 31(2):83-6. PubMed ID: 1559746
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recurrent acral lentigous melanoma successfully treated with Mohs' micrographic surgery. Case report and review of the literature].
    Mátrai Z; Plotár V; Liszkay G; Fejos Z; Vámosi A; Dubóczky Z; Rényi Vámos F; Vámosi Nagy I; Köves I; Bartal A; Schmidt E; Tóth L
    Orv Hetil; 2009 Jun; 150(23):1071-82. PubMed ID: 19470423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mohs micrographic surgery and multidisciplinary management.
    Vinciullo C
    Australas J Dermatol; 2019 Nov; 60(4):334-335. PubMed ID: 31215637
    [No Abstract]   [Full Text] [Related]  

  • 20. Mohs micrographic surgery: Facts and controversies.
    Levy RM; Hanke CW
    Clin Dermatol; 2010; 28(3):269-74. PubMed ID: 20541678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.